BIOMAT Database Logo BIOMAT Database Logo

Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. 1989

T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Children's Research Hospital, Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan.

Five neuroblastoma cell lines have been examined for the induction of HLA class II antigens by a recombinant gamma-interferon. The expression of HLA-DR and -DP was induced on up to 80% of cells in two of five neuroblastoma cell lines examined (KP-N-SI and KP-N-RT). Low expression of HLA-DR and -DP was induced on the SK-N-DZ line in the presence of recombinant gamma-interferon for 10 days. In contrast HLA-DQ was not induced on any of five neuroblastoma cell lines studied. HLA-DR and -DP antigen induction was reversible, falling to nondetectable levels when interferon was removed from the culture medium. The reinduction of interferon to the culture medium again induced HLA-DR and -DP antigen expression in a fashion similar to that originally observed. These results were confirmed by Northern blot analysis using a probe to HLA-DR alpha mRNA. Recombinant interferon appears to induce HLA class II expression at the level of gene transcription or posttranscription. The results also indicate that HLA-DR, -DP, and -DQ antigens are independently regulated. Treatment of neuroblastoma cell lines with gamma-interferon results in the induction of a differentiated phenotype. Although the cytokine gamma-interferon induces neurofilament expression in some of the cell lines, this was not the case for all lines studied. Thus no correlation could be established between the morphological differentiation and either HLA class II or neurofilament expression. In addition, no correlation between response to recombinant interferon and N-myc amplification was noted. The biological significance of HLA class II expression on neuroblastoma cell lines by gamma-interferon may be related to the differentiation stage of neuroblastoma cells or may enable gamma-interferon-treated neuroblastoma cells to be recognized by cytotoxic T-cells.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007382 Intermediate Filaments Cytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus. Tonofilaments,Neurofilaments,Filament, Intermediate,Filaments, Intermediate,Intermediate Filament,Neurofilament,Tonofilament
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines.
January 1984, European journal of immunology,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
[Differential expression of class II HLA antigens in human cells treated with gamma interferon].
January 1984, Giornale italiano di chemioterapia,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells.
November 1993, International journal of cancer,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Expression of HLA class I and class II antigens in human choriocarcinoma cell lines.
August 1986, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
March 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Modulation of the expression of HLA class II antigens by gamma interferon and phorbol ester TPA on myeloid leukaemic cell lines.
January 1986, Journal of immunogenetics,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
October 2003, Oncogene,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Quantitation of HLA class II antigens on B-cell lines.
June 1993, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma.
May 1988, Journal of immunology (Baltimore, Md. : 1950),
T Sugimoto, and Y Horii, and T Hino, and J T Kemshead, and H Kuroda, and T Sawada, and H Morioka, and J Imanishi, and H Inoko
Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma.
February 1985, International journal of cancer,
Copied contents to your clipboard!